Literature DB >> 17286837

Risk-taking and the adolescent brain: who is at risk?

Adriana Galvan1, Todd Hare, Henning Voss, Gary Glover, B J Casey.   

Abstract

Relative to other ages, adolescence is described as a period of increased impulsive and risk-taking behavior that can lead to fatal outcomes (suicide, substance abuse, HIV, accidents, etc.). This study was designed to examine neural correlates of risk-taking behavior in adolescents, relative to children and adults, in order to predict who may be at greatest risk. Activity in reward-related neural circuitry in anticipation of a large monetary reward was measured with functional magnetic resonance imaging, and anonymous self-report ratings of risky behavior, anticipation of risk and impulsivity were acquired in individuals between the ages of 7 and 29 years. There was a positive association between accumbens activity and the likelihood of engaging in risky behavior across development. This activity also varied as a function of individuals' ratings of anticipated positive or negative consequences of such behavior. Impulsivity ratings were not associated with accumbens activity, but rather with age. These findings suggest that during adolescence, some individuals may be especially prone to engage in risky behaviors due to developmental changes in concert with variability in a given individual's predisposition to engage in risky behavior, rather than to simple changes in impulsivity.

Entities:  

Mesh:

Year:  2007        PMID: 17286837     DOI: 10.1111/j.1467-7687.2006.00579.x

Source DB:  PubMed          Journal:  Dev Sci        ISSN: 1363-755X


  195 in total

1.  The development of memory efficiency and value-directed remembering across the life span: a cross-sectional study of memory and selectivity.

Authors:  Alan D Castel; Kathryn L Humphreys; Steve S Lee; Adriana Galván; David A Balota; David P McCabe
Journal:  Dev Psychol       Date:  2011-09-26

2.  Individual and peer factors associated with ketamine use among adolescents in Taiwan.

Authors:  Kun-Hua Lee; Yi-Chun Yeh; Pin-Chen Yang; Huang-Chi Lin; Peng-Wei Wang; Tai-Ling Liu; Cheng-Fang Yen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

3.  Peers increase adolescent risk taking by enhancing activity in the brain's reward circuitry.

Authors:  Jason Chein; Dustin Albert; Lia O'Brien; Kaitlyn Uckert; Laurence Steinberg
Journal:  Dev Sci       Date:  2011-03

Review 4.  Neurobiology of the adolescent brain and behavior: implications for substance use disorders.

Authors:  B J Casey; Rebecca M Jones
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-10-08       Impact factor: 8.829

Review 5.  Individual differences and developmental change in the ERN response: implications for models of ACC function.

Authors:  Sidney J Segalowitz; Jane Dywan
Journal:  Psychol Res       Date:  2008-11-21

6.  The adolescent brain.

Authors:  B J Casey; Sarah Getz; Adriana Galvan
Journal:  Dev Rev       Date:  2008

7.  An Overview of Judgment and Decision Making Research Through the Lens of Fuzzy Trace Theory.

Authors:  Roni Setton; Evan Wilhelms; Becky Weldon; Christina Chick; Valerie Reyna
Journal:  Xin Li Ke Xue Jin Zhan       Date:  2014-12

8.  Differential associations between impulsivity and risk-taking and brain activations underlying working memory in adolescents.

Authors:  Karni Panwar; Helena J V Rutherford; W Einar Mencl; Cheryl M Lacadie; Marc N Potenza; Linda C Mayes
Journal:  Addict Behav       Date:  2013-12-18       Impact factor: 3.913

9.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

10.  Ventral striatum activation to prosocial rewards predicts longitudinal declines in adolescent risk taking.

Authors:  Eva H Telzer; Andrew J Fuligni; Matthew D Lieberman; Adriana Galván
Journal:  Dev Cogn Neurosci       Date:  2012-09-03       Impact factor: 6.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.